Stevanato Group S.p.A. (NYSE:STVN) Expected to Announce Earnings of $0.12 Per Share

Brokerages expect that Stevanato Group S.p.A. (NYSE:STVN – Get Rating) will announce $0.12 earnings per share for the current quarter, according to Zacks Investment Research. Four analysts have issued estimates for Stevanato Group’s earnings, with estimates ranging from $0.11 to $0.13. Stevanato Group reported earnings of $0.15 per share in the same quarter last year, which would suggest a negative year-over-year growth rate of 20%. The firm is expected to announce its next earnings results on Monday, January 1st.

According to Zacks, analysts expect that Stevanato Group will report full-year earnings of $0.52 per share for the current financial year, with EPS estimates ranging from $0.50 to $0.53. For the next fiscal year, analysts forecast that the business will report earnings of $0.54 per share, with EPS estimates ranging from $0.52 to $0.58. Zacks’ EPS calculations are a mean average based on a survey of sell-side analysts that follow Stevanato Group.

Stevanato Group (NYSE:STVN – Get Rating) last posted its quarterly earnings data on Tuesday, May 10th. The company reported €0.11 ($0.11) EPS for the quarter, hitting the consensus estimate of €0.11 ($0.11). The company had revenue of €212.10 million during the quarter, compared to analyst estimates of €212.23 million. Stevanato Group had a net margin of 14.57% and a return on equity of 16.39%. Stevanato Group’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.13 earnings per share.

Several research analysts have commented on STVN shares. Wells Fargo & Company dropped their price objective on shares of Stevanato Group from $21.00 to $19.00 and set an “overweight” rating for the company in a research note on Monday, April 25th. Bank of America lowered their target price on shares of Stevanato Group from $30.00 to $24.00 and set a “buy” rating for the company in a research note on Wednesday, March 9th. Zacks Investment Research lowered shares of Stevanato Group from a “buy” rating to a “hold” rating in a research note on Thursday, March 10th. Morgan Stanley lowered their target price on shares of Stevanato Group from $30.00 to $22.00 and set an “overweight” rating for the company in a research note on Wednesday, March 9th. Finally, Citigroup lowered their price objective on shares of Stevanato Group from $27.00 to $23.00 and set a “buy” rating for the company in a research note on Wednesday, March 9th. Two investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Buy” and a consensus target price of €24.44 ($25.46).

A number of institutional investors have recently made changes to their positions in STVN. UBS Group AG raised its holdings in Stevanato Group by 79.9% in the first quarter. UBS Group AG now owns 1,799 shares of the company’s stock worth $36,000 after purchasing an additional 799 shares in the last quarter. Captrust Financial Advisors bought a new position in Stevanato Group in the third quarter worth about $56,000. First Horizon Advisors Inc. bought a new position in Stevanato Group in the first quarter worth about $65,000. Russell Investments Group Ltd. bought a new position in Stevanato Group in the fourth quarter worth about $93,000. Finally, Advisor Group Holdings Inc. bought a new position in Stevanato Group in the third quarter worth about $176,000. Institutional investors and hedge funds own 90.26% of the company’s stock.

NYSE STVN opened at €15.14 ($15.77) on Tuesday. The company has a quick ratio of 2.12, a current ratio of 2.48 and a debt-to-equity ratio of 0.22. The company has a fifty day moving average of €17.33 and a two-hundred day moving average of €19.24. The firm has a market capitalization of $4.47 billion and a price-to-earnings ratio of 27.04. Stevanato Group has a 52 week low of €13.35 ($13.91) and a 52 week high of €29.18 ($30.40).

About Stevanato Group (Get Rating)

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines.

See Also